期刊文献+

多发性骨髓瘤患者DLC-1基因甲基化及三氧化二砷诱导DLC-1基因去甲基化的研究 被引量:5

Hypermethylation of CpG island of DLC-1 gene and arsenic trioxide-induced DLC-1 gene demethylation in multiple myeloma
原文传递
导出
摘要 目的探讨人多发性骨髓瘤(MM)肝癌缺失基因1(DLC-1)启动子区CpG岛甲基化情况,以及三氧化二砷(As2O3)诱导DLC-1基因的去甲基化作用。方法采用甲基特异性PCR法(MSP)定性检测2008至2012年来自福建医科大学附属协和医院血液内科的52例MM患者DIC基因甲基化状态,反转录(RT)-PCR检测MM患者和人骨髓瘤U266细胞系DLC-1基因的表达情况;采用重亚硫酸盐测序PCR(BSP)法定量检测As203作用前、后人骨髓瘤细胞株U266其DLC-1基因的甲基化状态;荧光定量PCR检测U266细胞用药前、后DLC-1基因、DNA甲基转移酶基因(DNMTl、DNMT3a、DNMT3b)mRNA的表达变化。结果MM患者DLC-1基因的甲基化比例为71.15%(37/52)。U266细胞DLC-1基因呈甲基化,DLC-1基因不表达;经0.5、1.0、2.0pμmol/L As203作用后72h U266细胞DLC-1基因甲基化率由95.38%下降至63.07%、30.00%及7.69%;荧光定量PCR检测经0.5、1.0、2.0pμmol/L As2O3作用后72hU266细胞DLC-1基因mRNA表达与未加药组相比分别为其(1.60±0.09)、(3.66±0.17)、(5.29±0.15)倍,而DNMTl、DNMT3a、DNMT3b基因mRNA表达下调(均P〈0.05)。结论DLC-1基因甲基化在MM患者中较为常见,这可能为MM的诊断和治疗提供借鉴;As2O3可诱导DLC-1基因去甲基化,使DLC-1基因表达上调,恢复其活性,为MM去甲基化治疗提供新思路。 Objective To explore the role of hypemethylation of DLC-1 gene in the pathogenesis of multiple myeloma ( MM ) and examine the effects of arsenic trioxide ( As2 03 ) -induced demethylation of DLC-1 gene in U266 cell line. Methods The methylation status of DLC-1 gene was detected by methylation specific PCR (MSP) in MM patients from 2008 to 2012. And the expression of DLC-1 gene mRNA was determined by reverse transcription-polymerase chain reaction (RT-PCR). Methylation statuses of DLC-1 gene exposed to As2O3 were detected by bisulfite sequencing PCR (BSP). And the mRNA expressions of DLC-1 and DNA methyltransferase (DNMT1, T3a and 3b) were determined by real-time fluorescence quantitative PCR (RTFQ-PCR). Results Hypermethylation of CpG island of DLC-1 gene was observed in 37/52 (71.15%) MM patients. DLC-1 gene was not expressed after methylation. As2O3 could induce DLC-1 gene demethylation. After 72-houe treatments of 0. 5, 1.0 and 2.0 μmol/L As2O3 , the methylation rate of DLC-1 gene dropped from 95.38% to 63.07% , 30.00% and 7. 69% . As compared with the untreated group, the expression of DLC-1 gene mRNA increased to ( 1.60 ±0.09) , (3.66 ± 0. 17 ) and (5.29 ±0. 15) folds after exposures(all P 〈0. 05). And As2O3 could induce the expression of DNMT1,DNMrI3a, DNMT3b gene mRNA (all P 〈 0. 05). Conclusions Methylation of DLC-1 gene is essential in the pathogenesis of MM and may provide a new diagnostic technique and drug target for the treatment of MM. And As2 03 may activate the expression of DLC-1 gene through demethylation.
出处 《中华医学杂志》 CAS CSCD 北大核心 2014年第36期2816-2821,共6页 National Medical Journal of China
基金 国家自然科学基金(81370629) 国家自然科学基金青年科学基金(81300428) 国家临床重点专科建设项目 教育部高等学校博士学科点专项科研基金(20133518120002) 福建省自然科学基金(2011J1179) 福建省卫生厅青年科学基金(2010-01-07) 福建省血液病重点实验室基金(2009J1004) 福建省临床重点专科建设项目
关键词 多发性骨髓瘤 甲基化 DLC-1基因 三氧化二砷 U266细胞系 LMultiple myeloma Methylation DLC-1 gene Arsenic trioxide U266 cell line
  • 相关文献

参考文献20

  • 1汪娟,傅琤琤,吴德沛,孙爱宁,薛胜利,辛雪,胡晓慧,王荧,仇惠英,金正明,苗瞄,唐晓文,韩悦,马骁,何广胜,常伟荣,陈苏宁.自体造血干细胞移植治疗多发性骨髓瘤的回顾性疗效分析[J].中华医学杂志,2013,93(2):114-118. 被引量:13
  • 2Kocemba KA,Groen RW, van Andel H, et al. Transcriptionalsilencing of the Wnt-antagonist DKK1 by promoter methylation isassociated with enhanced Wnt signaling in advanced multiplemyeloma[ J]. PLoS One,2012, 7 :e30359.
  • 3Yuan BZ, Miller MJ, Keck CL, et al. Cloning, characterizationand chromosomal localization of a gene frequently deleted in humanliver cancer ( DLC-1 ) homologous to rat RhoGAP [ J ]. CancerRes, 1998,58: 2196-2199.
  • 4Yin XL, Pang JC,Ng HK. Identification of a region ofhomozygous deletion on 8p22-23. 1 in medulloblastoma [ J ].Oncogene,2002 ,21 : 1461-1468.
  • 5Dai Z, Jin Y. Promoter methylation of the DLC 1 gene and itsinhibitory effect on human colon cancer [ J ]. Oncol Hep ,2013 ,30 :1511-1517.
  • 6Low JS, Tao Q, Ng KM, et al. A novel isoform of the 8p22 tumorsuppressor gene DLC1 suppresses tumor growth and is frequentlysilenced in multiple common tumors [ J ]. Oncogene,2011,30,1923-1935.
  • 7Cui X, Wakai T,Shirai Y, et al. Arsenic trioxide inhibits DNAmethyltransferase and restores methylation-silenced genes in humanliver cancer cells[ J]. Hum Pathol,2006,37 :298-311.
  • 8傅海英,沈建箴,沈松菲,周华蓉.巢式MSP检测砷剂诱导人多发性骨髓瘤U266细胞系p16基因去甲基化及转录[J].中国实验血液学杂志,2007,15(1):79-85. 被引量:10
  • 9陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2007:712-717.
  • 10Herman JG, Graff JR, Myohanen S,et al. Methylat:on-specificPCR: a novel PCR assay for methylation status of CpG islands[J]. Proc Natl Acad Sci USA, 1996, 93: 9821-9826.

二级参考文献60

  • 1周华蓉,沈建箴,付海英,叶宝国,范丽萍,林福安.巢式MSP法检测恶性血液病细胞株p16基因启动子甲基化状态的研究[J].中国实验血液学杂志,2006,14(2):375-378. 被引量:13
  • 2沈建箴,周华蓉.去甲基化在治疗恶性血液病中的研究[J].中华内科杂志,2006,45(5):355-356. 被引量:8
  • 3张嘉玲,苏秀兰.去甲基化在肿瘤治疗中的作用[J].中国误诊学杂志,2006,6(23):4531-4533. 被引量:6
  • 4范丽萍,沈建箴,叶宝国,林福安,傅海英,周华蓉,沈松菲,喻爱芳.巢式MSP法检测急性白血病患者p16基因甲基化状态[J].中国实验血液学杂志,2007,15(2):258-261. 被引量:14
  • 5Fukuda K, Hibiya Y, Mutoh M, et al. Inhibition of activator protein 1 activity by berberine in human hepatoma ceils. Planta Med, 1999 ;65 (4) :381 - 383.
  • 6Herman JG, Graft JR, Myohanen, et al. Methylation-specific PCR : a novel PCR assay for methylation status of CpG island. Proc Natl Acad Sci USA, 1996 ;93 ( 18 ) : 9821 - 9826.
  • 7Palmisano WA, Divine KK, Saccomanno G, et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Research ,2000 ;60 (21) :5954 - 5958.
  • 8Allen A. Epigenetic alterations and cancer: new targets for therapy. Drugs,2007 ;10(10) :709 -712.
  • 9Roman-Gomez J, Jimemez-Velasco A, Agirre X, et al. Repetitive DNA hypomethylation in the advanced phase of chronic myeloid leukemia. Leuk Res,2008 ; 32 ( 3 ) :487 - 490.
  • 10EI-Shakankiry NH, Mossallam GI. p15 ( INK 4B ) and E-cadherin CpG island methylation is frequent in Egyptian acute myeloid Leukemia. J Egypt Nail Canc Inst,2006 ; 18 ( 3 ) :227 - 232.

共引文献190

同被引文献27

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部